Case Studies & Publications - TriNetX

Case Studies & Publications

Transforming Clinical Research. Advancing Healthcare.

TriNetX is dedicated to bridging the gap between clinical research and patient care through our cutting-edge data platform. Our case studies and publications reflect our commitment to providing actionable insights, fostering collaboration, and driving innovation in healthcare research.

Want to learn more about how TriNetX can support your research initiatives? Contact us for more information or schedule a demo to see our platform in action.

See TriNetX Case Studies

See TriNetX Scientific Publications

See TriNetX Publication Guidelines

See TriNetX Data Privacy Attestation

TriNetX Case Studies

Dive into our collection of case studies highlighting how TriNetX is making a tangible difference in healthcare. Our case studies offer a detailed look at how organizations are leveraging our platform to drive impactful research, streamline clinical trials, and accelerate the journey from data to discovery.

FEATURED CASE STUDY

East Lancashire Hospitals NHS Trust Leverages TriNetX to Automate Research Capabilities and Optimize Clinical Trial Patient Recruitment

CASE STUDY

 

 

Rapid Response and Deep Dive: University of New Mexico’s Clinical & Translational Science Center Simplifies Analytics and Accelerates Time to Insight with TriNetX Platform

CASE STUDY

 

Medical College of Wisconsin

 

Medical College of Wisconsin Leverages the TriNetX Platform to Win Grant Funding to Study Outcomes and Risk Factors for Sickle Cell Disease Patients with COVID-19

CASE STUDY

 

 

University of Oxford, U.K. Uses TriNetX Platform to Conduct Research on Mental Health Impact of COVID-19

CASE STUDY

 

 

TriNetX Helps Cuyahoga County’s MetroHealth System in Ohio Strive for Clinical Research Leadership Through Data Sharing

CASE STUDY

 

UTMB Map

 

Expanding and Accelerating Research at the University of Texas Medical Branch (UTMB) Blocker Burn Unit with TriNetX

CASE STUDY

 

 

Enhancing Research Studies, Increasing Clinical Trial Opportunities at West Virginia Clinical and Translational Science Institute

CASE STUDY

 

 

Penn State Increases Access to Data, Enhances Research Efforts by Joining TriNetX Research Network

Recent TriNetX Scientific Publications

Stay informed with the latest research and findings published by our partners and team members. Our publications section features peer-reviewed articles, white papers, and reports that demonstrate the impact of TriNetX’s technology in the field of clinical research.

Kaplan meier curves for cardiovascular events

Capture of Long COVID in TriNetX: A Descriptive Analysis

Comparing five equations to estimate glomerular filtration rate or creatinine clearance and assign individuals to KDIGO categories across the full age spectrum using real world data

Dagenais SRadi ZBurnham J, et al. Clin Transl Sci202417:e13726. DOI: 10.1111/cts.13726

A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data

Jia K, Kundrot S, Palchuk MB, et al. eBioMedicine, vol. 98, Dec. 2023, p.104888. DOI: 10.1016/j.ebiom.2023.104888

Sample of TriNetX Oncology Publications

Explore how TriNetX is transforming oncology research across Europe. Our robust data network and advanced analytics are facilitating groundbreaking studies that enhance our understanding of cancer treatment and patient outcomes.

Click the therapeutic areas below to access research examples:

TriNetX Lymphoma/Leukemia Research Publications

Behandlung indolenter Lymphome in Deutschland

Ergebnisse einer repräsentativen nationalen Erhebung

Treatment of Chronic Lymphocytic Leukemia in Germany Results of a representative population‐based survey in 2011

Indolente Non Hodgkin Lymphome

Trends in der Diagnose und in der Therapie in Deutschland (2006-2009)

TriNetX Multiple Myeloma Research Publications

Treatment Situation for Newly Diagnosed Multiple Myeloma (MM) Patients in Germany (GER)- First Results from a Representative Multicentre Treatment Survey. Session Type: Publication Only

Treatment Situation for Newly Diagnosed Multiple Myeloma Patients in Germany

First Results from a Representative Multicentre Treatment Survey

Baseline characteristics and survival outcomes of patients with tri exposed multiple myeloma in a German registry

Role of Bortezomib in the Treatment of Multiple Myeloma

First Results from a Representative Multicentre Treatment Survey in Germany

Treatment Situation for Newly Diagnosed Multiple Myeloma (MM) Patients in Germany (GER)- First Results from a Representative Multicentre Treatment Survey. Session Type: Publication Only

Anwendung neuer Therapien zur Behandlung des multiplen Myeloms

Ergebnisse einer repräsentativen multizentrischen Erhebung 2006

Baseline characteristics and survival outcomes of patients with tri exposed multiple myeloma in a German registry

Treatment of multiple myeloma in Germany

An update of a representative multicentre health care survey 2004‐2011


TriNetX Oncology GmbH is a wholly owned subsidiary of TriNetX, LLC.

TriNetX Contact Information for Physicians in Europe:
Tel: +49 761 – 38 39 94 – 0  |  Fax: +49 761 – 20 25 117  |  oncology@trinetx.com